Therapeutic Potential of the Ranibizumab Port Delivery System in the Treatment of AMD: Evidence to Date

Age-related macular degeneration (AMD) is one of the leading causes of blindness in older adults worldwide. The advent of intravitreal neutralization of vascular endothelial growth factor (VEGF) has revolutionized the management of patients with neovascular AMD, but current anti-VEGF therapies carry...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Eric R, Kaiser, Peter K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245454/
https://www.ncbi.nlm.nih.gov/pubmed/32546942
http://dx.doi.org/10.2147/OPTH.S194234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245454/
https://www.ncbi.nlm.nih.gov/pubmed/32546942
http://dx.doi.org/10.2147/OPTH.S194234

Ejemplares similares